Merck’s Keytruda is cleared in Europe as adjuvant therapy in kidney cancer
27 January 2022 - 11:03PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2023 to Mar 2024